Cancer & GI pipeline

Cancer & GI pipeline

Cancer
Product Description Indication Status Originator
Leuprorelin acetate (TAP-144SR) (A) 6-month depot formulation of leuprorelin, a luteinizing hormone releasing hormone(LHRH) agonist Prostate cancer Under review in EU Takeda
Velcade (A) Small molecule dipeptide boronic acid proteasome inhibitor First-line multiple

Read the full 441 word article

How to gain access

Continue reading with a
two-week free trial.